Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
暂无分享,去创建一个
F. Sakamaki | N. Nagaya | H. Oya | N. Nakanishi | S. Kyotani | N. Sato
[1] Robert O. Bonow,et al. Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition , 2004 .
[2] F. Sakamaki,et al. Increased Plasma P-Selectin and Decreased Thrombomodulin in Pulmonary Arterial Hypertension Were Improved by Continuous Prostacyclin Therapy , 2000, Circulation.
[3] G. Simonneau,et al. Thrombotic risk factors in pulmonary hypertension. , 2000, The European respiratory journal.
[4] K. Kerr,et al. Reoperative pulmonary thromboendarterectomy. , 1999, The Annals of thoracic surgery.
[5] K. Kerr,et al. Long-term outcome after pulmonary thromboendarterectomy. , 1999, American journal of respiratory and critical care medicine.
[6] S. Arcasoy,et al. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. , 1999, Chest.
[7] K. Hassell,et al. Altered hemostasis in pulmonary hypertension. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[8] R. Barst,et al. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. , 1997, Circulation.
[9] R. Marlar,et al. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. , 1996, Chest.
[10] J. Piette,et al. Plasma levels of thrombomodulin in pulmonary hypertension. , 1996, The American journal of medicine.
[11] G. Simonneau,et al. Continuous Infusion of Prostacyclin Decreases Plasma Levels of t-PA and PAI-1 in Primary Pulmonary Hypertension , 1995, Thrombosis and Haemostasis.
[12] J. Amiral,et al. Membrane thrombomodulin levels are decreased during hypoxia and restored by cAMP and IBMX. , 1995, Thrombosis research.
[13] M. Olman,et al. Parallel Analysis of Tissue‐Type Plasminogen Activator and Type 1 Plasminogen Activator Inhibitor in Plasma and Endothelial Cells Derived From Patients With Chronic Pulmonary Thromboemboli , 1994, Circulation.
[14] J. Amiral,et al. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. , 1993, Thrombosis research.
[15] Y. Ikeda,et al. Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome , 1993, British journal of haematology.
[16] R. Tarazi,et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. , 1993, The Journal of thoracic and cardiovascular surgery.
[17] K. Peterson,et al. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. , 1992, Radiology.
[18] T. Hayashi,et al. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[19] S. Kimura,et al. Plasma thrombomodulin in health and diseases. , 1990, Blood.
[20] W. Auger,et al. Chronic major-vessel thromboembolic pulmonary hypertension. , 1990, Circulation.
[21] J. Brody,et al. Abnormalities of thrombomodulin and tissue plasminogen activator in occluded aortocoronary grafts detected by immunohistochemistry. , 1988, Transactions of the Association of American Physicians.
[22] J. S. Bower,et al. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease. , 1981, The American review of respiratory disease.
[23] C. Esmon,et al. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, The Journal of biological chemistry.